The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tuberculosis (TB) Diagnostics Market Research Report 2024
Synopsis
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global Tuberculosis (TB) Diagnostics market was valued at US$ 2630 million in 2023 and is anticipated to reach US$ 3592.2 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.
Report Scope
The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis (TB) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Segment by Type
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Segment by Application
Diagnostic Laboratories
Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global Tuberculosis (TB) Diagnostics market was valued at US$ 2630 million in 2023 and is anticipated to reach US$ 3592.2 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.
Report Scope
The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis (TB) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Segment by Type
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Segment by Application
Diagnostic Laboratories
Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis (TB) Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2019-2030)
2.2 Tuberculosis (TB) Diagnostics Growth Trends by Region
2.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tuberculosis (TB) Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Tuberculosis (TB) Diagnostics Market Dynamics
2.3.1 Tuberculosis (TB) Diagnostics Industry Trends
2.3.2 Tuberculosis (TB) Diagnostics Market Drivers
2.3.3 Tuberculosis (TB) Diagnostics Market Challenges
2.3.4 Tuberculosis (TB) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue
3.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis (TB) Diagnostics Revenue
3.4 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio
3.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2023
3.5 Tuberculosis (TB) Diagnostics Key Players Head office and Area Served
3.6 Key Players Tuberculosis (TB) Diagnostics Product Solution and Service
3.7 Date of Enter into Tuberculosis (TB) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis (TB) Diagnostics Breakdown Data by Type
4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2025-2030)
5 Tuberculosis (TB) Diagnostics Breakdown Data by Application
5.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tuberculosis (TB) Diagnostics Market Size (2019-2030)
6.2 North America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
6.4 North America Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tuberculosis (TB) Diagnostics Market Size (2019-2030)
7.2 Europe Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
7.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tuberculosis (TB) Diagnostics Market Size (2019-2030)
9.2 Latin America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Detail
11.1.2 Danaher Business Overview
11.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction
11.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
11.1.5 Danaher Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Tuberculosis (TB) Diagnostics Introduction
11.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 BD
11.4.1 BD Company Detail
11.4.2 BD Business Overview
11.4.3 BD Tuberculosis (TB) Diagnostics Introduction
11.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
11.4.5 BD Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction
11.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 Hologic
11.6.1 Hologic Company Detail
11.6.2 Hologic Business Overview
11.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction
11.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
11.6.5 Hologic Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction
11.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
11.7.5 Qiagen Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Detail
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction
11.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
11.8.5 BioMerieux Recent Development
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Detail
11.9.2 Hain Lifescience Business Overview
11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction
11.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
11.9.5 Hain Lifescience Recent Development
11.10 Oxford Immunotec
11.10.1 Oxford Immunotec Company Detail
11.10.2 Oxford Immunotec Business Overview
11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction
11.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2019-2024)
11.10.5 Oxford Immunotec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
